Aptus Pharma

{
  "main_header": {
    "sid": 10039782,
    "name": "Aptus Pharma",
    "stock_name": "Aptus Pharma",
    "full_name": "Aptus Pharma Ltd",
    "name_url": "stocks-analysis/aptus-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "308.05",
    "chg": -6.25,
    "chgp": "-1.99%",
    "dir": -1,
    "prev_price": "314.30",
    "mcapval": "539.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544529,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE15XJ01010",
    "curr_date": "Sep 02, 10:16 AM",
    "curr_time": "10:30 AM",
    "last_traded_at": "Sep 02, 10:16 AM IST",
    "bse_nse_vol": 7600,
    "exc_status": "Active",
    "traded_date": "Sep 02, 2026",
    "traded_date_str": "2026 09 02",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aptus-pharma-10039782-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 1,
    "sid": "10039782",
    "stock_news_url": "https://www.marketsmojo.com/news/aptus-pharma-10039782"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "24-Aug-2026",
      "details": "Aptus Pharma Limited - Press release regarding - Aptus Pharma Limited charts next growth phase with focus on manufacturing pan-India expansion and global markets",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "21-Aug-2026",
      "details": "SUB: Submission of Annual Report for the FY 2025-26 comprising of the Notice of Annual General Meeting Directors Report Independent Auditors Report and Audited Financial Statements",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "21-Aug-2026",
      "details": "Intimation of investor presentation under regulation 30 of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aptus Pharma Ltd has announced <strong>3:2</strong> bonus issue, ex-date: 12 May 26",
          "dt": "2026-05-12",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News